Search
Onkure Therapeutics Inc
OKURAdd to Watchlist
2.300USD
-0.050-2.13%
Close 10-08 16:00（ET）
92.92MMarket Cap
LossP/E TTM
Onkure Therapeutics Inc (OKUR) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to Onkure Therapeutics Inc in the past month.
Buy
2 Strong Buy
3 Buy
1 Hold
0 Sell
0 Strong Sell
Target Price
15.800USD+517.19%
OKUR Analyst Recommendation Trends
In the current month, OKUR has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. OKUR average Analyst price target in the last month is 15.800.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2
2
2
2
2
2
2
2
3
3
3
3
3
4
4
4
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
6
6
6
6
Financial Forecasting
Based on analysts' estimates, OKUR EPS is projected to reach -0.410 in FY2026Q3, following reported EPS of -0.308 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.15
-0.74
-0.54
-0.41
-0.43
Actual
-0.99
-1.11
-0.31
--
--
Surprise
+13.80%
-49.28%
+42.48%
--
--
FAQs
What is Onkure Therapeutics Inc's price target?
Analysts forecast that Onkure Therapeutics Inc's price target is USD 32.00, with the highest forecast at USD 34.00 and the lowest forecast at USD 21.00.
How have Onkure Therapeutics IncOKUR's recent earnings per share performed?
The market expectation was USD -0.31, while Onkure Therapeutics IncOKUR's earnings per share (EPS) for the previous quarter was USD -1.11. EPS for the next quarter is expected at USD -0.41.
What is the analyst rating for Onkure Therapeutics Inc?
Based on the ratings of Onkure Therapeutics Inc's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.